TABLE 3.
Test | [AgVO3*] | AH Plus | Endofill | Sealer 26 | Sealapex |
---|---|---|---|---|---|
Flow | 0% | 36.2±0.13a | 45.2±0.39a | 43.6±0.63a | 31.1±0.11a |
2.5% | 30.2±0.15ab | 38.1±0.15b | 40.0±0.26a | 27.1±0.28a | |
5% | 24.6±0.18b | 37.5±0.66b | 45.3±0.10a | 27.4±0.07a | |
10% | 18.2±0.08c | 35.6±0.21b | 42.4±0.34a | 25.1±0.05a | |
Radiopacity | 0% | 4.73±0.22a | 5.00±0.12a | 3.91±0.19a | 4.63±0.10a |
2.5% | 4.90±0.05b | 4.52±0.10b | 4.20±0.07ab | 4.46±0.11b | |
(+3.6%) | (-9.6%) | (+7.4%) | (-3.7%) | ||
5% | 4.88±0.07ab | 5.07±0.14a | 3.83±0.41ac | 4.41±0.13b | |
(+3.2%) | (+1.4%) | (-2%) | (-4.8%) | ||
10% | 4.93±0.08b | 5.01±0.10a | 4.26±0.29ab | 4.64±0.11a | |
(+4.2%) | (+0.2%) | (+8.9%) | (+0.2%) |
Same letters represent statistical similarity in the same column. The statistical correlation between tests has not been evaluated. Numbers in parentheses represent variation in average radiopacity values in comparison with respective control groups
AgVO3: nanostructured silver vanadate decorated with silver nanoparticles